Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin’s lymphoma
| Autor: | Jurczak, W. *, Zinzani, P.L., Gaidano, G., Goy, A., Provencio, M., Nagy, Z., Robak, T., Maddocks, K., Buske, C., Ambarkhane, S., Winderlich, M., Dirnberger-Hertweck, M., Korolkiewicz, R., Blum, K.A. |
|---|---|
| Zdroj: | In Annals of Oncology May 2018 29(5):1266-1272 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|